Replies to post #349245 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Negating details not presented.

Is there anything fundamentally wrong the[with] the trial, how it was run or the data gathered, that would bring its integrity into question?

This is the question that I want answered, with specific notation and reference to verbiage in the released trial results.

Tell us, please; what's in there that makes blarcamesine a failure against Rett syndrome in non-pediatric patients? Be SPECIFIC, please. Tell us exactly why blarcamesine cannot be approved by the FDA to treat non-pediatric Rett syndrome? Inquiring minds want to know --- the details.